Bicycle Therapeutics
BCYC
14 hedge funds and large institutions have $85.1M invested in Bicycle Therapeutics in 2020 Q1 according to their latest regulatory filings, with 4 funds opening new positions, 3 increasing their positions, 3 reducing their positions, and 0 closing their positions.
53% more capital invested
Capital invested by funds: $55.7M → $85.1M (+$29.5M)
40% more funds holding
Funds holding: 10 → 14 (+4)
1.46% more ownership
Funds ownership: 32.97% → 34.43% (+1.5%)
0% more funds holding in top 10
Funds holding in top 10: 2 → 2 (0)
0% more repeat investments, than reductions
Existing positions increased: 3 | Existing positions reduced: 3
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
Victory Capital Management
San Antonio,
Texas
|
+$3.87M |
| 2 |
Renaissance Technologies
New York
|
+$240K |
| 3 |
Point72 Asset Management
Stamford,
Connecticut
|
+$229K |
| 4 |
Squarepoint
New York
|
+$167K |
| 5 |
Morgan Stanley
New York
|
+$41.3K |
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
PCM
Pentwater Capital Management
Naples,
Florida
|
-$511K |
| 2 |
LCM
Laurion Capital Management
New York
|
-$209K |
| 3 |
Millennium Management
New York
|
-$75.8K |
| Name | Holding | Trade Value |
Shares Change |
Change in Stake |
|
|---|---|---|---|---|---|
|
TCM
1
Tybourne Capital Management
Hong Kong
| $26.7M | – | – | – |
|
|
SHI
2
SV Health Investors
Boston,
Massachusetts
| $26.1M | – | – | – |
|
|
AVA
3
Atlas Venture Advisors
Boston,
Massachusetts
| $18.6M | – | – | – |
|
|
4
Victory Capital Management
San Antonio,
Texas
| $6.43M | +$3.87M | +303,972 | +224% |
|
|
5
Point72 Asset Management
Stamford,
Connecticut
| $5.47M | +$229K | +18,000 | +5% |
|
|
LCM
6
Laurion Capital Management
New York
| $868K | -$209K | -16,398 | -22% |
|
|
7
Renaissance Technologies
New York
| $257K | +$240K | +18,800 | New |
|
|
8
Millennium Management
New York
| $228K | -$75.8K | -5,949 | -28% |
|
|
9
Squarepoint
New York
| $179K | +$167K | +13,108 | New |
|
|
PCM
10
Pentwater Capital Management
Naples,
Florida
| $171K | -$511K | -40,087 | -76% |
|
|
11
Morgan Stanley
New York
| $44K | +$41.3K | +3,245 | +32,450% |
|
|
CSS
12
Cubist Systematic Strategies
Stamford,
Connecticut
| $4K | +$3.75K | +294 | New |
|
13
Osaic Holdings
Scottsdale,
Arizona
| $1K | +$1.27K | +100 | New |
|
BCYC Hedge Fund Activity: Q1 2020 in Review
14 of the 4,539 institutional investors tracked by Wall St. Rank reported a position in Bicycle Therapeutics (BCYC) for Q1 2020, worth a combined $85.1M — up 53% from $55.7M a quarter earlier.
Buyers outnumbered sellers: 4 funds opened new BCYC positions and 0 closed out — a net gain of 4 holders — while 3 added to existing stakes and 3 trimmed.
The largest buyer was Victory Capital Management, adding an estimated $3.87M. The largest seller was Pentwater Capital Management, cutting an estimated $511K.
- 14 institutional investors held Bicycle Therapeutics (BCYC) as of Q1 2020, up from 10 in Q4 2019.
- Funds reported $85.1M of Bicycle Therapeutics stock for Q1 2020, up 53% quarter-over-quarter.
- 4 funds opened new Bicycle Therapeutics positions in Q1 2020 and 0 closed out, a net change of +4 holders.
- The largest Bicycle Therapeutics buyer in Q1 2020 was Victory Capital Management, an estimated $3.87M added.
- The largest Bicycle Therapeutics seller in Q1 2020 was Pentwater Capital Management, an estimated $511K sold.
Based on aggregated 13F filings for Q1 2020.